STAA Q1 2017 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q1 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$20M+5.6% YoY

Gross Profit

$15M71.6% margin

Operating Income

-$2M-10.3% margin

Net Income

-$2M-10.8% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-8.1%

Cash Flow

Operating Cash Flow

-$625,000

Free Cash Flow

-$938,000

Stock-Based Comp.

$510,000

Balance Sheet

Total Assets

$65M

Total Liabilities

$28M

Stockholders' Equity

$37M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$19M	+5.6%
Gross Profit	$15M	$13M	+12.2%
Operating Income	-$2M	-$10M	+79.2%
Net Income	-$2M	-$8M	+72.6%

Revenue Segments

Implantable Collamer Lenses

$15M75%

Intraocular Lenses

$5M23%

Other Surgical Products

$473,0002%

Geographic Segments

Other Countries

$9M43%

CHINA

$4M22%

JAPAN

$4M19%

UNITED STATES

$2M10%

KOREA, REPUBLIC OF

$1M7%